ホームページへ
4.6/5
TrustPilot

ブレーメンで最高の乳癌化学療法医師 - トップ2名の医師

ドイツのトップ乳癌化学療法医師と価格を比較。こちらで最適なマッチングを見つけてください

ドイツの3名のトップ乳癌化学療法専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

トップ医師

2

ドイツ

レビュー

14000+

実際の患者より

医師サービスで最良価格の国を選択

トップ各国の乳癌化学療法価格を比較

国をタップしてトップ医師と価格を表示

Ukraine
Turkey
Mexico
Thailand
Czech Republic
Poland
$1,200 - $2,500
$1,200 - $3,500
$2,000 - $5,000
$3,000 - $7,000
$3,000 - $6,000
$3,500 - $6,500
$0
$2,000
$4,000
$6,000

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

Bernd Hertenstein

  • 所在地: ドイツ, ブレーメン
  • クリニック:
    4.3
    Bremen-Mitte Clinic
  • Dr. Bernd Hertenstein is a renowned Clinical Oncologist with 32 years of experience in providing chemotherapy and radiotherapy to cancer patients.

    • Tumour Marker Blood Test
    • Bone Marrow Transplant
    • Autologous bone marrow transplantation
    • Allogenic bone marrow transplantation from a related donor
    • Allogenic bone marrow transplantation from an unrelated donor
    • Radiofrequency ablation of the liver
    • Chemotherapy for liver cancer
    • Chemoembolization of the liver
    • Chemotherapy for breast cancer
    • Leukemia chemotherapy
    • Stem cell transplantation
    • Contributor to numerous publications
  • 続きを読む
診察
お問い合わせください

Jorg Groticke

  • 認定:
  • 所在地: ドイツ, ブレーメン
  • クリニック:
    4.3
    Bremen-Mitte Clinic
  • ヨルク・グロティッケ教授は、ブレーメン・ミッテ病院の腫瘍学および血液学センターの主任医師です。医師は、血液悪性腫瘍および消化管腫瘍の治療を専門としています。

     

    専門分野

     

    1987年に教授は免疫学の専門研修を修了しました。1993年に、ヨルク・グロティッケはブレーメン・ミッテ病院の内科で博士号を取得しました。2007年にヨルク・グロティッケ博士はブレーメン・ミッテ内科センターの上級医師になりました。2005年以降、医師は腫瘍学センターを指揮し、ブレーメン腫瘍学会で革新的な癌治療について講義を行っています。

     

     

    会員

    • ドイツ血液学および医療腫瘍学会;
    • ドイツ根拠に基づく医療ネットワーク;
    • ドイツ癌学会;
    • ブレーメン癌学会。

    Professor Jorg Groticke


    予約を取る

     

    グロティッケ教授との予約を取るには、ウェブサイトにリクエストを送信してください。Bookimedの医師が連絡して相談の適切な時間と日付を設定します。

     

     

    医療セカンドオピニオンを取得する

    相談のためにドイツに行く必要はありません。ヨルク・グロティッケ教授は遠隔での相談を提供しています。診断や治療計画に疑問がある場合、また有名な医師からの推薦を受けたい場合、セカンドオピニオンを取得してください。

  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3

Germanyの1022名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか?

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方:内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください:
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察:ドイツのトップ乳癌化学療法専門家(2026)

Bookimedはドイツの乳癌化学療法リクエスト10件を調整し、2名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Which oncologists are regarded among the best for breast-cancer chemotherapy in Germany?

Top oncologists for breast cancer chemotherapy in Germany include board-certified specialists at accredited cancer centers. These experts typically hold German Cancer Society certifications and participate in multidisciplinary tumor boards. Leading doctors like Dr. Viola Fox and Dr. Séverine Iborra integrate molecular diagnostics with personalized treatment protocols.

  • Specialized expertise: Dr. Bernd Hertenstein at Bremen-Mitte Clinic has 30+ years of experience in oncology.
  • Molecular diagnostics: Dr. Viola Fox provides personalized chemotherapy plans based on specific genetic tumor markers.
  • Academic leadership: Professor Boris Pfaffenbach has authored over 130 publications on malignant internal organ tumors.
  • Certified centers: Specialists at Nordwest Clinic and Solingen operate within DKG-certified breast cancer departments.

Bookimed Expert Insight: Data shows that choosing a dually qualified specialist often improves the patient journey. For example, Dr. Séverine Iborra in Solingen is a specialist in both gynecology and oncology. This combination allows one doctor to manage surgical diagnostics and chemotherapy protocols concurrently. Patients at these centers benefit from consolidated care without needing separate visits for imaging and treatment.

Patient Consensus: Patients emphasize that receiving a clear roadmap of the chemotherapy cycles and side-effect management is vital. Many found that large university hospitals offer the best coordination for pathology and imaging under one roof. They also noted that having English-speaking staff significantly reduces the stress of undergoing intensive treatment abroad.

How can I verify that a breast-cancer doctor in Germany is properly qualified?

Qualified breast cancer doctors in Germany must hold Facharzt certification in oncology or gynecology. You can verify their expertise by checking for associations with centers accredited by the German Cancer Society. Top specialists often lead multidisciplinary tumor boards to personalize chemotherapy protocols and manage complex cases.

  • Board certification: Confirm the doctor is a Facharzt in internal medicine, hematology, or oncology.
  • Center accreditation: Look for affiliations with facilities accredited by the German Cancer Society (DKG).
  • Academic leadership: Many leading specialists hold professor titles and lead dedicated university hospital departments.
  • Molecular expertise: Qualified oncologists often have additional specialist qualifications in genetics or molecular diagnostics.

Bookimed Expert Insight: German oncology structures prioritize interdisciplinary leadership. For example, Dr. Séverine Iborra at Solingen leads a specialized Senology center, while Prof. Boris Pfaffenbach heads an entire oncology department. This dual focus means your chemotherapy plan is overseen by a specialist who also manages the broader clinical department and participates in integrated tumor boards.

Patient Consensus: Patients note that well-qualified doctors often provide a written protocol immediately after the first consultation. They feel more confident when they see a multidisciplinary team, including surgeons and oncologists, collaborating on their specific case details. Many were relieved to find that reputable specialists encourage second opinions to confirm the best treatment path.

Can international patients obtain an independent second opinion from breast-cancer specialists in Germany?

International patients can obtain independent second opinions from breast cancer specialists at leading German university hospitals. Board-certified oncologists provide these reviews through multidisciplinary tumor boards. They evaluate pathology reports and imaging to verify diagnoses. Remote consultations via video are frequently available for international cases.

  • Specialized expertise: Prof. Jorg Groticke offers remote second opinions for complex oncology cases at Bremen-Mitte Clinic.
  • Accredited centers: Prof. Boris Pfaffenbach leads oncology at a hospital certified by the German Cancer Society.
  • Top-rated practitioners: Prof. Elke Jaeger is recognized by Focus rating as a leading German oncologist.
  • Personalized approach: Dr. Viola Fox specializes in molecular diagnostics for tailored breast cancer therapy plans.

Bookimed Expert Insight: Data shows that choosing specialists in academic centers like Bremen-Mitte or Solingen provides access to extensive research backgrounds. For instance, Prof. Boris Pfaffenbach has authored over 130 publications. This academic focus ensures patients receive opinions based on the latest clinical trials and innovative protocols. This is particularly valuable for rare or aggressive breast cancer subtypes.

Patient Consensus: Patients note that providing complete records is essential for a meaningful review. Many were relieved when specialists confirmed their current plans or refined treatment steps. They found that major clinics provide detailed written reports that are easy to share with local doctors.

Do German breast-cancer doctors typically prefer giving chemotherapy before or after surgery?

German breast cancer specialists use both neoadjuvant and adjuvant chemotherapy based on individual tumor characteristics. Neoadjuvant therapy before surgery is favored for aggressive or large tumors to shrink them. This approach often allows for breast-conserving surgery instead of a full mastectomy.

  • Tumor reduction: Chemotherapy before surgery helps shrink large masses to improve surgical outcomes.
  • Response monitoring: Doctors track how the cancer reacts to drugs during neoadjuvant treatment.
  • Recurrence prevention: Adjuvant chemotherapy after surgery targets remaining cells to stop cancer returning.
  • Customized protocols: Decisions depend on receptor status, tumor size, and lymph node involvement.

Bookimed Expert Insight: German clinics like Academic Hospital Solingen and Nordwest Clinic utilize multidisciplinary boards to decide the chemotherapy sequence. Dr. Séverine Iborra at Solingen leads a dedicated breast clinic where molecular diagnostics guide these decisions. Data shows that German professors, such as Dr. Boris Pfaffenbach, often integrate extensive research into personalized protocols. This ensures the timing of chemotherapy aligns with the latest clinical findings for each specific cancer subtype.

Patient Consensus: Patients note that the treatment sequence feels like a collaborative decision between oncologists and surgeons. They appreciate that doctors explain how shrinking the tumor first can lead to less invasive surgery. Many felt reassured when their medical team adjusted the plan based on how the tumor responded to initial doses.

What advanced or targeted therapies do breast-cancer doctors in Germany use alongside standard chemotherapy?

Breast cancer doctors in Germany use targeted therapies like HER2-inhibitors and CDK4/6 inhibitors alongside chemotherapy. Experts such as Dr. Viola Fox at Medical Center Solingen apply molecular diagnostics to select precise antibody-drug conjugates. This personalized approach often includes immunotherapy and specialized interventional radiology to improve outcomes.

  • Molecular diagnostics: Dr. Viola Fox uses genetic testing to guide personalized monoclonal antibody selection.
  • HER2-targeted therapy: Doctors combine antibodies like Trastuzumab with chemotherapy for HER2-positive breast cancer.
  • CDK4/6 inhibition: Specialists at Nordwest Clinic provide advanced endocrine therapies for hormone-receptor-positive cases.
  • Localized procedures: Dr. Bernd Hertenstein performs chemoembolization and radiofrequency ablation for complex tumor cases.

Bookimed Expert Insight: German oncology centers stand out by staffing dual-qualified specialists. For instance, Dr. Viola Fox holds certifications in both oncology and genetics. This allows clinics to integrate molecular tumor boards directly into the treatment planning phase. Patients benefit from real-time genomic insights that determine if they qualify for the latest clinical trials.

Patient Consensus: Patients find that treatment plans are strictly driven by detailed pathology results like HER2 and BRCA status. Many note the frequency of neoadjuvant therapy, which combines targeted drugs with chemotherapy to shrink tumors before surgery. They emphasize feeling reassured by the highly protocolized nature of German cancer centers.